---
layout: minimal-medicine
title: Epirubicin
---

# Epirubicin
### Generic Name
Epirubicin

### Usage
Epirubicin is an anthracycline antibiotic and antineoplastic agent primarily used in the treatment of various cancers.  Its main application is as part of combination chemotherapy regimens for breast cancer, often administered after surgery (adjuvant therapy) to reduce the risk of cancer recurrence.  It's also used, albeit less frequently and often off-label, in the treatment of other cancers such as esophageal cancer, gastric cancer, osteosarcoma, and soft tissue sarcoma.  The specific regimen and dosage will vary considerably depending on the type of cancer, its stage, and the patient's overall health.  Always consult a healthcare professional for accurate treatment guidance.

### Dosage
Epirubicin dosage is highly individualized and determined by the oncologist based on several factors including the patient's body surface area (BSA), type of cancer, overall health, and response to treatment.  It is typically administered intravenously (IV).  There are no standardized pediatric dosage recommendations as safety and efficacy in children haven't been established.

**Adult Dosage Examples (IV):**  Dosage is expressed as mg/m² (milligrams per square meter of body surface area).  The following are examples of regimens and should not be considered exhaustive or a substitute for professional medical advice.

* **Breast Cancer (Adjuvant):**  Common dosages range from 100-120 mg/m² every 3-4 weeks.  However, numerous other regimens exist involving different combinations of drugs and schedules (e.g., CEF-120, FEC-100, EC, EP, or EC, FEC with or without paclitaxel, FEC followed by pertuzumab + trastuzumab + docetaxel, and CEF regimens). Each regimen has specific dosage instructions and should only be administered under strict medical supervision.

* **Other Cancers (Off-Label):**  Dosages vary widely depending on the type of cancer and combination therapy used.  Regimens such as ECF, ECX, EOF, EOX often involve epirubicin at 50 mg/m² every 21 days, but again, this is just an example, and exact dosages should be determined and monitored by a medical oncologist.


**Dosage Adjustments:** Dosage adjustments may be necessary based on factors like liver and kidney function,  body weight (especially in obese patients), and the occurrence of side effects.  Lower doses are generally recommended for patients with impaired liver or kidney function.  In cases of severe toxicity, treatment may be temporarily interrupted or the dose reduced.


### Side Effects
Epirubicin, like other chemotherapy drugs, can cause various side effects. The severity and frequency of side effects can vary significantly between individuals.

**Common Side Effects (>10%):**

* Alopecia (hair loss)
* Anemia (low red blood cell count)
* Amenorrhea (absence of menstruation)
* Conjunctivitis (inflammation of the eye)
* Diarrhea
* Hot flashes
* Injection site reactions
* Lethargy (fatigue)
* Leukopenia (low white blood cell count)
* Mucositis (inflammation of mucous membranes)
* Nausea and vomiting
* Neutropenia (low neutrophil count)
* Thrombocytopenia (low platelet count)

**Less Common but Serious Side Effects:**

* Cardiomyopathy (heart muscle damage)
* Myocardial toxicity (damage to the heart muscle), potentially leading to congestive heart failure.
* Severe myelosuppression (bone marrow suppression), increasing the risk of infections and bleeding.
* Secondary malignancies (e.g., leukemia)
* Extravasation (leakage from the vein during IV administration), which can cause severe tissue damage.
* Acute myeloid leukemia
* Myelodysplastic syndrome


If you experience any concerning side effects, contact your doctor immediately.


### How it Works
Epirubicin works by interfering with the processes essential for cancer cell growth and division.  It's an anthracycline that intercalates (inserts itself) into DNA, preventing it from replicating properly.  This action inhibits DNA and RNA synthesis, ultimately leading to cancer cell death. Epirubicin also causes DNA strand breaks through the inhibition of topoisomerase II, an enzyme involved in DNA replication.


### Precautions
* **Hypersensitivity:** Epirubicin is contraindicated in patients with a known hypersensitivity to it, other anthracyclines, or anthracenediones.
* **Cardiac Function:** Epirubicin can cause significant cardiac toxicity, including cardiomyopathy and congestive heart failure.  Cardiac function should be carefully monitored before, during, and after treatment.  Pre-existing heart conditions are a contraindication.
* **Bone Marrow Suppression:** Epirubicin can suppress bone marrow function, leading to myelosuppression (low blood cell counts). Regular blood tests to monitor blood cell counts are crucial.
* **Liver and Kidney Function:**  Patients with severe liver or kidney impairment should receive lower doses or have treatment modified.
* **Pregnancy and Breastfeeding:** Epirubicin is categorized as pregnancy category D, meaning it poses a risk to the fetus.  Women of childbearing age should use effective contraception during treatment.  Breastfeeding is not recommended during and for at least 7 days after the last dose.
* **Drug Interactions:** Epirubicin can interact with several other medications. It's crucial to inform your healthcare provider of all medications you are taking.
* **Extravasation:** If epirubicin leaks out of the vein during administration (extravasation), it can cause severe tissue damage.  Immediate action is required.


### FAQs

* **Q: How long does it take for epirubicin to work?**  A: The response to epirubicin varies, and it's not possible to give a specific timeframe.  Tumor shrinkage may take weeks or months.

* **Q: How is epirubicin stored?** A: Storage instructions will be provided on the medication packaging and should be followed carefully. Typically, it requires refrigeration.

* **Q: Are there long-term effects of epirubicin?** A: Yes, potential long-term effects include heart damage and secondary malignancies.  Regular follow-up care is important.

* **Q: Can I drive after receiving epirubicin?** A:  Fatigue and other side effects can impair driving ability.  Follow your doctor's advice on driving restrictions.

* **Q:  What should I do if I miss a dose?** A: Contact your healthcare provider immediately; never adjust the dosage yourself.

* **Q: What should I do if epirubicin extravasates (leaks out of the vein)?**  A: This is a medical emergency. Notify your healthcare provider immediately.

**Disclaimer:** This information is for educational purposes only and should not be considered medical advice. Always consult with a healthcare professional for diagnosis and treatment of any medical condition.  The information provided here is not exhaustive and should not be used as a substitute for professional medical guidance.  Dosage and treatment regimens are highly individualized.
